IDEAS home Printed from https://ideas.repec.org/a/gam/jdataj/v10y2025i5p61-d1644256.html
   My bibliography  Save this article

Time-Course Transcriptomic Dataset of Gallic Acid-Induced Human Cervical Carcinoma HeLa Cell Death

Author

Listed:
  • Ho Man Tang

    (School of Life Sciences, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China)

  • Peter Chi Keung Cheung

    (School of Life Sciences, Chinese University of Hong Kong, Shatin, Hong Kong SAR, China)

Abstract

Gallic acid is a natural phenolic acid that displays potent anti-cancer activity in a large variety of cell types and rodent cancer xenograft models. Although research has focused on determining the efficacy of gallic acid against various types of human cancer cells, the molecular mechanisms governing the anti-cancer properties of gallic acid remain largely unclear, and a transcriptomic study of gallic acid-induced cancer cell death has rarely been reported. Therefore, we applied time-course bulk RNA-sequencing to elucidate the molecular signature of gallic acid-induced cell death in human cervical cancer HeLa cells, as this is a widely used in vitro model in the field. Our RNA-sequencing dataset covers the early (2 nd hour), middle (4 th , 6 th hour), and late (9 th hour) stages of the cell death process after exposure of HeLa cells to gallic acid, and the untreated (0 th hour) cells served as controls. Differential expression of messenger RNAs (mRNAs) and long non-coding RNAs (lncRNAs) was identified at each time point in the dataset. In summary, this dataset is a unique and valuable resource with which the scientific community can explore the molecular mechanisms and identify druggable regulators of the gallic acid-induced cell death process in cancer.

Suggested Citation

  • Ho Man Tang & Peter Chi Keung Cheung, 2025. "Time-Course Transcriptomic Dataset of Gallic Acid-Induced Human Cervical Carcinoma HeLa Cell Death," Data, MDPI, vol. 10(5), pages 1-12, April.
  • Handle: RePEc:gam:jdataj:v:10:y:2025:i:5:p:61-:d:1644256
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2306-5729/10/5/61/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/2306-5729/10/5/61/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Neil Vasan & José Baselga & David M. Hyman, 2019. "A view on drug resistance in cancer," Nature, Nature, vol. 575(7782), pages 299-309, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wei Xu & Sau Har Lee & Fengjun Qiu & Li Zhou & Xiaoling Wang & Tingjie Ye & Xudong Hu, 2021. "Association of SMAD4 loss with drug resistance in clinical cancer patients: A systematic meta-analysis," PLOS ONE, Public Library of Science, vol. 16(5), pages 1-14, May.
    2. Heathcliff Dorado García & Fabian Pusch & Yi Bei & Jennifer Stebut & Glorymar Ibáñez & Kristina Guillan & Koshi Imami & Dennis Gürgen & Jana Rolff & Konstantin Helmsauer & Stephanie Meyer-Liesener & N, 2022. "Therapeutic targeting of ATR in alveolar rhabdomyosarcoma," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Xiaoting Sun & Wenhai Sui & Zepeng Mu & Sisi Xie & Jinxiu Deng & Sen Li & Takahiro Seki & Jieyu Wu & Xu Jing & Xingkang He & Yangang Wang & Xiaokun Li & Yunlong Yang & Ping Huang & Minghua Ge & Yihai , 2023. "Mirabegron displays anticancer effects by globally browning adipose tissues," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    4. Shigekazu Murakami & Shannon M. White & Alec T. McIntosh & Chan D. K. Nguyen & Chunling Yi, 2023. "Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    5. Anna Gogleva & Dimitris Polychronopoulos & Matthias Pfeifer & Vladimir Poroshin & Michaël Ughetto & Matthew J. Martin & Hannah Thorpe & Aurelie Bornot & Paul D. Smith & Ben Sidders & Jonathan R. Dry &, 2022. "Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    6. Weili Wang & Huizhen Zheng & Jun Jiang & Zhi Li & Dongpeng Jiang & Xiangru Shi & Hui Wang & Jie Jiang & Qianqian Xie & Meng Gao & Jianhong Chu & Xiaoming Cai & Tian Xia & Ruibin Li, 2022. "Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    7. Tom Nyen & Mélanie Planque & Lilian Wagensveld & Joao A. G. Duarte & Esther A. Zaal & Ali Talebi & Matteo Rossi & Pierre-René Körner & Lara Rizzotto & Stijn Moens & Wout Wispelaere & Regina E. M. Baid, 2022. "Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    8. Rong Cai & Chiagoziem Ngwadom & Ravindra Saxena & Jayashree Soman & Chase Bruggeman & David P. Hickey & Rafael Verduzco & Caroline M. Ajo-Franklin, 2024. "Creation of a point-of-care therapeutics sensor using protein engineering, electrochemical sensing and electronic integration," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    9. Anastasia Samarkina & Markus Kirolos Youssef & Paola Ostano & Soumitra Ghosh & Min Ma & Beatrice Tassone & Tatiana Proust & Giovanna Chiorino & Mitchell P. Levesque & Sandro Goruppi & Gian Paolo Dotto, 2023. "Androgen receptor is a determinant of melanoma targeted drug resistance," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    10. Weier Bao & Ming Liu & Jiaqi Meng & Siyuan Liu & Shuang Wang & Rongrong Jia & Yugang Wang & Guanghui Ma & Wei Wei & Zhiyuan Tian, 2021. "MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
    11. Maria Kleshnina & Sabrina Streipert & Joel S. Brown & Kateřina Staňková, 2023. "Game Theory for Managing Evolving Systems: Challenges and Opportunities of Including Vector-Valued Strategies and Life-History Traits," Dynamic Games and Applications, Springer, vol. 13(4), pages 1130-1155, December.
    12. Hongyue Zheng & Ke Zhang & Jigang Piao & Chaofeng Mu & Xiaowei Xie & Mengying Cheng & Tianxiang Yue & Jiang Sun & Bin Li & Yinghui Wei & Hangsheng Zheng & Lai Jiang & Douae Nihed Habiballah & Fanzhu L, 2025. "In situ valence-transited arsenic nanosheets for multi-modal therapy of colorectal cancer," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    13. Irati Macaya & Marta Roman & Connor Welch & Rodrigo Entrialgo-Cadierno & Marina Salmon & Alba Santos & Iker Feliu & Joanna Kovalski & Ines Lopez & Maria Rodriguez-Remirez & Sara Palomino-Echeverria & , 2023. "Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    14. Gustavo Arango-Argoty & Elly Kipkogei & Ross Stewart & Gerald J. Sun & Arijit Patra & Ioannis Kagiampakis & Etai Jacob, 2025. "Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    15. Yanmei Zhang & Qifan Hu & Yuquan Pei & Hao Luo & Zixuan Wang & Xinxin Xu & Qing Zhang & Jianli Dai & Qianqian Wang & Zilian Fan & Yongcong Fang & Min Ye & Binhan Li & Mailin Chen & Qi Xue & Qingfeng Z, 2024. "A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    16. Dongzhe Wu & Xiaolin Gao & Yongjin Shi & Hao Wang & Wendi Wang & Yanbin Li & Zicheng Zheng, 2022. "Association between Handgrip Strength and the Systemic Immune-Inflammation Index: A Nationwide Study, NHANES 2011–2014," IJERPH, MDPI, vol. 19(20), pages 1-12, October.
    17. Chunge Zhong & Wen-Jie Jiang & Yingjia Yao & Zexu Li & You Li & Shengnan Wang & Xiaofeng Wang & Wenjuan Zhu & Siqi Wu & Jing Wang & Shuangshuang Fan & Shixin Ma & Yeshu Liu & Han Zhang & Wenchang Zhao, 2024. "CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    18. Jorge Gómez Tejeda Zañudo & Romualdo Barroso-Sousa & Esha Jain & Qingchun Jin & Tianyu Li & Jorge E. Buendia-Buendia & Alyssa Pereslete & Daniel L. Abravanel & Arlindo R. Ferreira & Eileen Wrabel & Ka, 2024. "Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    19. Shadi Shafighi & Agnieszka Geras & Barbara Jurzysta & Alireza Sahaf Naeini & Igor Filipiuk & Alicja Rączkowska & Hosein Toosi & Łukasz Koperski & Kim Thrane & Camilla Engblom & Jeff E. Mold & Xinsong , 2024. "Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jdataj:v:10:y:2025:i:5:p:61-:d:1644256. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.